Variables | OS (model 0) | Â | OS (model 3) | Â |
---|---|---|---|---|
 | Crude HR(95%CI) | Crude P | Adjusted HR(95%CI) | Adjusted P |
Lung cancer | ||||
 CTI < 4.71 | ref |  | ref |  |
 CTI ≥ 4.71 | 1.51 (1.16–1.97) | 0.002 | 1.22 (0.93–1.61) | 0.151 |
Esophagus cancer | ||||
 CTI < 4.71 | ref |  | ref |  |
 CTI ≥ 4.71 | 2.64 (1.61–4.34) |  < 0.001 | 2.11 (1.05–4.21) | 0.035 |
Gastric cancer | ||||
 CTI < 4.71 | ref |  | ref |  |
 CTI ≥ 4.71 | 1.70 (1.21–2.4) | 0.002 | 1.28 (0.86–1.9) | 0.221 |
Colorectal cancer | ||||
 CTI < 4.71 | ref |  | ref |  |
 CTI ≥ 4.71 | 3.24 (2.15–4.89) |  < 0.001 | 2.29 (1.42–3.71) | 0.001 |
Female tumor | ||||
 CTI < 4.71 | ref |  | ref |  |
 CTI ≥ 4.71 | 3.02 (1.32–6.92) | 0.009 | 1.51 (0.49–4.59) | 0.472 |
Other cancer | ||||
 CTI < 4.71 | ref |  | ref |  |
 CTI ≥ 4.71 | 2.47 (1.63–3.73) |  < 0.001 | 1.82 (1.15–2.89) | 0.011 |